People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A Texas judge revealed that her husband used a bulk of his life savings to help pay for her treatment for clinical depression ...

Many people with depression and anxiety in the U.S. could benefit from medication but do not receive any treatment, psychiatrist Mark Olfson told Newsweek.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

A new study from an international team of researchers has identified hundreds of new genetic variants linked to increased ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The city’s police department has put a focus on officer mental health and well-being. That’s a big cultural change because ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression. Here's what ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...